Clinical trial
Taxol Carboplatin and Erythropoetin
NCT00158379 · North Eastern German Society of Gynaecological Oncology, Other · Completed
Key facts
| NCT number | NCT00158379 |
|---|---|
| Title | Taxol Carboplatin and Erythropoetin |
| Official title | Carboplatin With Following Taxol® Therapy Under Additional Application of Epoetin Alfa (ERYPO ®) With Female Patients With Advanced Ovarian Cancer FIGO IA/G3 - IV |
| Lead sponsor | North Eastern German Society of Gynaecological Oncology, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug |
| Interventions | Paclitaxel |
| Enrollment | 105 |
| Start date | Jul 1, 2003 |
| Primary completion | Apr 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Sep 12, 2005 |
| Last update posted | Feb 6, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: